Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion molecules

Liu,Shi-Quan; Su,Ying-Jie; Qin,Meng-Bin; Mao,Ye-Bo; Huang,Jie-An; Tang,Guo-Du

doi:10.3892/ijo.2012.1733

Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion molecules

Authors:
- Shi-Quan Liu
- Ying-Jie Su
- Meng-Bin Qin
- Ye-Bo Mao
- Jie-An Huang
- Guo-Du Tang
View Affiliations

Affiliations: Department of Gastroenterology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Autonomous Region 530021, P.R. China
Published online on: December 12, 2012 https://doi.org/10.3892/ijo.2012.1733
Pages: 617-626

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Studies suggest a tumor-promoting function of sphingosine kinase 1 (SphK1) in some types of human tumors, however, its effect on colon cancer is still unclear. The aims of this study were to investigate the roles of SphK1 in the progression and tumor cell phenotypic changes in colon cancer. Moreover, the focal adhesion kinase (FAK) pathway and the expression of intercellular adhesion molecule‑1 (ICAM‑1) and vascular cell adhesion molecule‑1 (VCAM‑1) were detected to explore the mechanisms of SphK1 action. In this study, the expression of SphK1, FAK and phospho-FAK (p-FAK) was analyzed in 66 surgical specimens of primary colon cancer and matched adjacent normal tissues by immunohistochemistry and western blotting. In addition, N,N-dimethylsphingosine (DMS), SphK1 DNA and shRNA transfection were used to regulate the expression and activity of SphK1 in the LOVO colon cancer cell line. Tumor cell phenotypic changes were analyzed by cell viability, invasion and apoptosis assays. Results showed that the expression of SphK1, FAK and p-FAK in colon cancer tissues were significantly stronger compared to those in matched normal tissues. There was a close correlation between the expression of SphK1 and FAK or p-FAK and the co-expression of SphK1, FAK and p-FAK significantly associated with histological grade, Dukes' stage, lymph node metastasis and distant metastasis. Overexpression of SphK1 after DNA transfection enhanced tumor cell viability and invasiveness, but suppressed cell apoptosis. In contrast, suppression of SphK1 by DMS and shRNA reduced tumor cell viability and invasiveness, but promoted cell apoptosis. The expression of FAK, p-FAK, ICAM-1 and VCAM-1 in LOVO cells were increased with the overexpression of SphK1 but decreased with the suppression of SphK1. These findings indicate that SphK1 regulates tumor cell proliferation, apoptosis and invasion, which ultimately contributes to tumor progression and malignancy phenotype in colon cancer. FAK pathway, ICAM-1 and VCAM-1 may play critical roles in this SphK1‑mediated effect.

View Figures

View References

1.	Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
2.	Pitson SM: Regulation of sphingosine kinase and sphingolipid signaling. Trends Biochem Sci. 36:97–107. 2011. View Article : Google Scholar : PubMed/NCBI
3.	Gamble JR, Sun WY, Li X, Hahn CN, Pitson SM, Vadas MA and Bonder CS: Sphingosine kinase-1 associates with integrin {alpha}V{beta}3 to mediate endothelial cell survival. Am J Pathol. 175:2217–2225. 2009.PubMed/NCBI
4.	Bergelin N, Blom T, Heikkilä J, et al: Sphingosine kinase as an oncogene: autocrine sphingosine 1-phosphate modulates ML-1 thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-alpha and ERK1/2. Endocrinology. 150:2055–2063. 2009. View Article : Google Scholar
5.	Li W, Yu CP, Xia JT, et al: Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res. 15:1393–1399. 2009. View Article : Google Scholar : PubMed/NCBI
6.	Pchejetski D, Doumerc N, Golzio M, et al: Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models. Mol Cancer Ther. 7:1836–1845. 2008. View Article : Google Scholar : PubMed/NCBI
7.	Kawamori T, Kaneshiro T, Okumura M, et al: Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J. 23:405–414. 2009. View Article : Google Scholar : PubMed/NCBI
8.	Nemoto S, Nakamura M, Osawa Y, et al: Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation. J Biol Chem. 284:10422–10432. 2009. View Article : Google Scholar
9.	Wang H, Maurer BJ, Liu YY, et al: N-(4-Hydroxyphenyl) retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing. Mol Cancer Ther. 7:2967–2976. 2008. View Article : Google Scholar : PubMed/NCBI
10.	Kohno M, Momoi M, Oo ML, et al: Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol Cell Biol. 26:7211–7223. 2006. View Article : Google Scholar : PubMed/NCBI
11.	Schwock J, Dhani N and Hedley DW: Targeting focal adhesion kinase signaling in tumor growth and metastasis. Expert Opin Ther Targets. 14:77–94. 2010. View Article : Google Scholar : PubMed/NCBI
12.	Hao HF, Naomoto Y, Bao XH, et al: Progress in researches about focal adhesion kinase in gastrointestinal tract. World J Gastroenterol. 15:5916–5923. 2009. View Article : Google Scholar : PubMed/NCBI
13.	Leve F, Marcondes TG, Bastos LG, Rabello SV, Tanaka MN and Morgado-Díaz JA: Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA-Rock and Src-FAK signalling in colon cancer cells. Eur J Pharmacol. 671:7–17. 2011. View Article : Google Scholar : PubMed/NCBI
14.	Dia VP and Gonzalez de Mejia E: Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to α5β1 integrin and suppresses FAK/ERK/NF-κB signaling. Cancer Lett. 313:167–180. 2011.PubMed/NCBI
15.	Zhao J, Singleton PA, Brown ME, Dudek SM and Garcia JG: Phosphotyrosine protein dynamics in cell membrane rafts of sphingosine-1-phosphate-stimulated human endothelium: role in barrier enhancement. Cell Signal. 21:1945–1960. 2009. View Article : Google Scholar : PubMed/NCBI
16.	Lee OH, Lee DJ, Kim YM, Kim YS, Kwon HJ, Kim KW and Kwon YG: Sphingosine 1-phosphate stimulates tyrosine phosphorylation of focal adhesion kinase and chemotactic motility of endothelial cells via the G(i) protein-linked phospholipase C pathway. Biochem Biophys Res Commun. 268:47–53. 2000. View Article : Google Scholar
17.	Gibbs TC, Rubio MV, Zhang Z, Xie Y, Kipp KR and Meier KE: Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells. Prostate. 69:1493–1506. 2009. View Article : Google Scholar : PubMed/NCBI
18.	Pettus BJ, Bielawski J, Porcelli AM, et al: The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha. FASEB J. 17:1411–1421. 2003. View Article : Google Scholar : PubMed/NCBI
19.	Cuvillier O, Ader I, Bouquerel P, Brizuela L, Malavaud B, Mazerolles C and Rischmann P: Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting. Curr Mol Pharmacol. 3:53–65. 2010. View Article : Google Scholar : PubMed/NCBI
20.	Nagahashi M, Ramachandran S, Kim EY, et al: Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. Cancer Res. 72:726–735. 2012. View Article : Google Scholar : PubMed/NCBI
21.	Maceyka M, Harikumar KB, Milstien S and Spiegel S: Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 22:50–60. 2012. View Article : Google Scholar : PubMed/NCBI
22.	Hao H, Naomoto Y, Bao X, Watanabe N, et al: Focal adhesion kinase as potential target for cancer therapy (Review). Oncol Rep. 22:973–979. 2009.PubMed/NCBI
23.	Lechertier T and Hodivala-Dilke K: Focal adhesion kinase and tumour angiogenesis. J Pathol. 226:404–412. 2012. View Article : Google Scholar : PubMed/NCBI
24.	Stokes JB, Adair SJ, Slack-Davis JK, et al: Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment. Mol Cancer Ther. 10:2135–2145. 2011. View Article : Google Scholar : PubMed/NCBI
25.	Yu HG, Tong SL, Ding YM, et al: Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase. Int J Cancer. 119:2724–2732. 2006. View Article : Google Scholar : PubMed/NCBI
26.	Kobayashi H, Boelte KC and Lin PC: Endothelial cell adhesion molecules and cancer progression. Curr Med Chem. 14:377–386. 2007. View Article : Google Scholar : PubMed/NCBI
27.	Shah N, Cabanillas F, McIntyre B, Feng L, et al: Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas. Leuk Lymphoma. 53:50–56. 2012. View Article : Google Scholar : PubMed/NCBI
28.	Lu X, Mu E, Wei Y, Riethdorf S, et al: VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell. 20:701–714. 2011.PubMed/NCBI
29.	Dymicka-Piekarska V, Guzinska-Ustymowicz K, Kuklinski A and Kemona H: Prognostic significance of adhesion molecules (sICAM-1, sVCAM-1) and VEGF in colorectal cancer patients. Thromb Res. 129:e47–e50. 2012. View Article : Google Scholar : PubMed/NCBI
30.	Alexiou D, Karayiannakis AJ, Syrigos KN, Zbar A, Kremmyda A, Bramis I and Tsigris C: Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery. Eur J Cancer. 37:2392–2397. 2001. View Article : Google Scholar
31.	Kase H, Hattori Y, Jojima T, et al: Globular adiponectin induces adhesion molecule expression through the sphingosine kinase pathway in vascular endothelial cells. Life Sci. 81:939–943. 2007. View Article : Google Scholar
32.	Fong YC, Lin CY, Su YC, et al: CCN6 enhances ICAM-1 expression and cell motility in human chondrosarcoma cells. J Cell Physiol. 227:223–232. 2012. View Article : Google Scholar : PubMed/NCBI
33.	Petzold T, Orr AW, Hahn C, Jhaveri KA, Parsons JT and Schwartz MA: Focal adhesion kinase modulates activation of NF-kappaB by flow in endothelial cells. Am J Physiol Cell Physiol. 297:C814–C822. 2009. View Article : Google Scholar
34.	Taglia L, Matusiak D, Matkowskyj KA and Benya RV: Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase. Am J Physiol Gastrointest Liver Physiol. 292:G182–G190. 2007. View Article : Google Scholar